Jackson Finl Analyst Ratings
Jefferies Maintains Hold on Jackson Finl, Raises Price Target to $70
Commercial Metals Analyst Ratings
B of A Securities Maintains Buy on Commercial Metals, Lowers Price Target to $69
Jackson Finl Analyst Ratings
Evercore ISI Trims Price Target on Jackson Financial to $73 From $75, Keeps In Line Rating
Old National Analyst Ratings
Barclays Maintains Overweight on Old National, Raises Price Target to $22
Cytokinetics Analyst Ratings
JP Morgan Maintains Overweight on Cytokinetics, Lowers Price Target to $65
HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $90 Price Target
Cytokinetics Analyst Ratings
Cytokinetics Analyst Ratings
BNP Paribas Exane Initiates Terreno Realty at Outperform Rating With $68 Price Target
Essent Group Ltd: KBW raises price target from $64 to $65
J.P. Morgan Securities: Reiterates the Cytokinetics (CYTK.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $78.00 to $78.00.
Cytokinetics Analyst Ratings
JMP Securities Reiterates Market Outperform on Cytokinetics, Maintains $78 Price Target
Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK) and Canopy Growth (CGC)
Piper Sandler: Maintaining the SouthState (SSB.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $95.00 to $98.00.